Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.1 USD | -0.27% | -1.23% | -31.84% |
08/05 | Transcript : Amphastar Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
08/05 | Amphastar Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.84% | 206.42Cr | |
+29.38% | 68TCr | |
+30.34% | 57TCr | |
-3.80% | 36TCr | |
+17.64% | 33TCr | |
+4.23% | 28TCr | |
+16.21% | 24TCr | |
+9.66% | 21TCr | |
-6.83% | 20TCr | |
+7.45% | 17TCr |
- Stock Market
- Equities
- AMPH Stock
- News Amphastar Pharmaceuticals, Inc.
- BofA Securities Initiates Amphastar Pharmaceuticals at Neutral Rating With $63 Price Target